Proteomics

Dataset Information

85

Quantitative Analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide


ABSTRACT: Polycythemia vera (PV) is a myeloproliferative disorder arising in pluripotent stem cells that causes an abnormal erythrocyte mass. More than 90% of PV patients have a mutation in JAK2 protein that is closely associated with the erythrocyte membrane. We report findings on quantitative analysis of the erythrocyte membrane proteins differentially regulated in PV patients treated with hydroxycarbamide.
Kottahachchi et al., EuPA Open Proteomics 7, 43-53
Quantitative analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide
DOI:10.1016/j.euprot.2015.04.001
http://www.sciencedirect.com/science/article/pii/S2212968515000100

INSTRUMENT(S): QSTAR, Q Exactive

ORGANISM(S): Homo sapiens  

TISSUE(S): Erythrocyte

DISEASE(S): Not Available

SUBMITTER: Susumu Imanishi  

LAB HEAD: Garry L. Corthals

PROVIDER: PXD001532 | Pride | 2015-05-11

REPOSITORIES: Pride

Similar Datasets

2018-10-24 | PXD002339 | Pride
2010-07-24 | GSE23018 | GEO
2015-01-23 | PXD001082 | Pride
2016-07-03 | E-GEOD-75848 | ArrayExpress
2008-10-26 | E-GEOD-7638 | ArrayExpress
2016-07-03 | E-GEOD-75845 | ArrayExpress
2007-11-26 | E-SGRP-9 | ArrayExpress
2013-05-10 | E-BUGS-135 | ArrayExpress
2016-01-06 | E-GEOD-76526 | ArrayExpress
2015-06-08 | ST000189 | MetabolomicsWorkbench